SPDR S&P Pharmaceuticals ETF
XPH
XPH
85 hedge funds and large institutions have $335M invested in SPDR S&P Pharmaceuticals ETF in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4.38% more ownership
Funds ownership: 57.27% → 61.65% (+4.4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less capital invested
Capital invested by funds: $337M → $335M (-$1.99M)
Holders
85
Holding in Top 10
2
Calls
$1.27M
Puts
$511K
Top Buyers
| 1 | +$29.4M | |
| 2 | +$3.57M | |
| 3 | +$2.74M | |
| 4 |
SI
Stephens Inc
Little Rock,
Arkansas
|
+$2.73M |
| 5 |
DC
Davenport & Co
Richmond,
Virginia
|
+$2.3M |
Top Sellers
| 1 | -$18.6M | |
| 2 | -$4.59M | |
| 3 | -$3.6M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$3.05M |
| 5 |
Jane Street
New York
|
-$2.75M |